September - 2011
| Previous Next | Showing Journal 7 of 14 |
Genetic Basis for In Vivo Daptomycin Resistance in EnterococciCesar A. Arias, Diana Panesso, Danielle M. McGrath, NEJM, 2011, 365:892-900 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
September |
Previous Comments
No Comments yet.
Comment
There is no doubt VRE has become a major problem as a coloniser and infective organism. Linezolid and Quinupristin are limited by treatment failure and toxocity. Daptomycin is used off-label, but suffers the limitation of resistance acquired during treatment.
...